Organigram Global Inc. (OGI) stock
OGINasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.71−0.02 (-2.36%)
Close on Nov 17, 2026Market cap $95.05MP/E –Yield –
Organigram Global price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Organigram Global's price to sales ratio was 0.6× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 0.6× to 8.4×, with a median of 1.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | −0.6 |
| 2025 | Dec 31, 2025 | 1.2× | −0.1 |
| 2024 | Dec 31, 2024 | 1.2× | +0.3 |
| 2023 | Dec 29, 2023 | 0.9× | −1.4 |
| 2022 | Dec 30, 2022 | 2.3× | −6.1 |
| 2021 | Dec 31, 2021 | 8.4× | +4.6 |
| 2020 | Dec 31, 2020 | 3.8× | −2.4 |
| 2019 | Dec 31, 2019 | 6.2× | −42.9 |
| 2018 | Dec 31, 2018 | 49.0× | – |
See a number that looks wrong?